Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Gyre Therapeutics, Inc. (GYRE) vs Inventiva S.A. Sponsored ADR (IVA)

Gyre Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Gyre Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($777.2M and $767.8M). Inventiva S.A. Sponsored ADR grew revenue faster over the last twelve months: 547.9% against 10.7%. Gyre Therapeutics, Inc. has the higher net margin (−13.7% vs −750.3%) and the lower return on invested capital (−8.51% vs 0.00%). Across the 17 metrics below, Inventiva S.A. Sponsored ADR leads on 9 and Gyre Therapeutics, Inc. on 8.

Valuation

Metric GYRE IVA Biotechnology median
P/E n/m n/m 7.88
P/S 6.35 8.95 11.47
P/B 5.19 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 5.71 5.19 10.73
Earnings yield (2.72%) (105.73%) (28.84%)
Free cash flow yield (0.96%) (104.14%) (23.03%)

Profitability

Metric GYRE IVA Biotechnology median
Gross margin 94.15% 0.00% 65.16%
Operating margin (10.53%) 0.00% 0.00%
Net margin (13.73%) (750.28%) 0.00%
Free cash flow margin (6.12%) 0.00% 0.00%
Return on equity (11.75%) 0.00% (57.72%)
Return on assets (9.08%) 0.00% (49.22%)
Return on invested capital (8.51%) 0.00% 0.00%

Growth

Metric GYRE IVA Biotechnology median
Revenue growth (TTM) 10.72% 547.89% 5.64%
EPS growth (last fiscal year) (60.00%) 35.44% —
Revenue growth, 5-year CAGR 40.96% 8.33% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GYRE IVA Biotechnology median
Debt to equity 0.00 (6.41) 0.00
Current ratio 4.26 2.96 4.73
Net debt to EBITDA (3.74) 0.29 0.96

Dividend

Metric GYRE IVA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GYRE IVA Biotechnology median
Market cap 777.23m 767.78m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack